[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537335":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":26,"responsibleParty":209,"collaborators":20,"id":211,"slug":212,"hasResults":213,"nctId":214,"briefTitle":215,"officialTitle":216,"acronym":20,"eligibilityCriteria":217,"healthyVolunteers":213,"sex":218,"minAge":219,"maxAge":20,"enrollmentInfo":220,"targetDuration":20,"studyType":223,"phases":224,"briefSummary":226,"conditions":227,"keywords":233,"overallStatus":29,"whyStopped":20,"lastUpdateSubmitDate":238,"lastUpdatePostDateStruct":239,"startDateStruct":242,"completionDateStruct":244,"leadSponsor":246,"locationsCount":247},{"fullName":5,"class":6},"Xencor, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose escalation and Dose Expansion of XmAb541","EXPERIMENTAL","Intravenous or Subcutaneous administration",[13],"Biological: XmAb541",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","XmAb541","Monoclonal bispecific antibody",[9],null,[22],{"name":23,"role":24,"phone":20,"phoneExt":20,"email":25},"XmAb541-01 Central Contact","CONTACT","info541-01@xencor.com",[27,41,50,59,69,79,89,99,109,119,129,138,147,157,167,177,187,197],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":20},"City of Hope","RECRUITING","Duarte","California","91010","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-117.97729,34.13945,{"lat":39,"lon":38},{"facility":42,"status":29,"city":43,"state":31,"zip":44,"country":33,"countryCode":34,"cosmosGeoPoint":45,"geoPoint":49,"contacts":20},"Stanford","Palo Alto","94304",{"type":36,"coordinates":46},[47,48],-122.14302,37.44188,{"lat":48,"lon":47},{"facility":51,"status":29,"city":52,"state":31,"zip":53,"country":33,"countryCode":34,"cosmosGeoPoint":54,"geoPoint":58,"contacts":20},"University of California","San Francisco","94158",{"type":36,"coordinates":55},[56,57],-122.41942,37.77493,{"lat":57,"lon":56},{"facility":60,"status":29,"city":61,"state":62,"zip":63,"country":33,"countryCode":34,"cosmosGeoPoint":64,"geoPoint":68,"contacts":20},"Moffitt Cancer Center","Tampa","Florida","33612",{"type":36,"coordinates":65},[66,67],-82.45843,27.94752,{"lat":67,"lon":66},{"facility":70,"status":29,"city":71,"state":72,"zip":73,"country":33,"countryCode":34,"cosmosGeoPoint":74,"geoPoint":78,"contacts":20},"Winship Cancer Institute, Emory University","Atlanta","Georgia","30322",{"type":36,"coordinates":75},[76,77],-84.38798,33.749,{"lat":77,"lon":76},{"facility":80,"status":29,"city":81,"state":82,"zip":83,"country":33,"countryCode":34,"cosmosGeoPoint":84,"geoPoint":88,"contacts":20},"University of Chicago Medical Center","Chicago","Illinois","60637",{"type":36,"coordinates":85},[86,87],-87.65005,41.85003,{"lat":87,"lon":86},{"facility":90,"status":29,"city":91,"state":92,"zip":93,"country":33,"countryCode":34,"cosmosGeoPoint":94,"geoPoint":98,"contacts":20},"Indiana University Melvin and Bren Simon Comprehensive Cancer Center","Indianapolis","Indiana","46202",{"type":36,"coordinates":95},[96,97],-86.15804,39.76838,{"lat":97,"lon":96},{"facility":100,"status":29,"city":101,"state":102,"zip":103,"country":33,"countryCode":34,"cosmosGeoPoint":104,"geoPoint":108,"contacts":20},"Karmanos Cancer Institute","Detroit","Michigan","48201",{"type":36,"coordinates":105},[106,107],-83.04575,42.33143,{"lat":107,"lon":106},{"facility":110,"status":29,"city":111,"state":112,"zip":113,"country":33,"countryCode":34,"cosmosGeoPoint":114,"geoPoint":118,"contacts":20},"University of Minnesota","Minneapolis","Minnesota","55455",{"type":36,"coordinates":115},[116,117],-93.26384,44.97997,{"lat":117,"lon":116},{"facility":120,"status":29,"city":121,"state":122,"zip":123,"country":33,"countryCode":34,"cosmosGeoPoint":124,"geoPoint":128,"contacts":20},"The John Theruer Cancer Center at Hackensack University Medical Center","Hackensack","New Jersey","07601",{"type":36,"coordinates":125},[126,127],-74.04347,40.88593,{"lat":127,"lon":126},{"facility":130,"status":29,"city":131,"state":131,"zip":132,"country":33,"countryCode":34,"cosmosGeoPoint":133,"geoPoint":137,"contacts":20},"Icahn School of Medicine at Mount Sinai","New York","10029",{"type":36,"coordinates":134},[135,136],-74.00597,40.71427,{"lat":136,"lon":135},{"facility":139,"status":29,"city":140,"state":131,"zip":141,"country":33,"countryCode":34,"cosmosGeoPoint":142,"geoPoint":146,"contacts":20},"Montefiore Einstein Comprehensive Cancer Center","The Bronx","10461",{"type":36,"coordinates":143},[144,145],-73.86641,40.84985,{"lat":145,"lon":144},{"facility":148,"status":29,"city":149,"state":150,"zip":151,"country":33,"countryCode":34,"cosmosGeoPoint":152,"geoPoint":156,"contacts":20},"The Ohio State University","Columbus","Ohio","43210",{"type":36,"coordinates":153},[154,155],-82.99879,39.96118,{"lat":155,"lon":154},{"facility":158,"status":29,"city":159,"state":160,"zip":161,"country":33,"countryCode":34,"cosmosGeoPoint":162,"geoPoint":166,"contacts":20},"OU Health Stephenson Cancer Center","Oklahoma City","Oklahoma","73104",{"type":36,"coordinates":163},[164,165],-97.51643,35.46756,{"lat":165,"lon":164},{"facility":168,"status":29,"city":169,"state":170,"zip":171,"country":33,"countryCode":34,"cosmosGeoPoint":172,"geoPoint":176,"contacts":20},"UPMC Hillman Cancer Center","Pittsburgh","Pennsylvania","15232",{"type":36,"coordinates":173},[174,175],-79.99589,40.44062,{"lat":175,"lon":174},{"facility":178,"status":29,"city":179,"state":180,"zip":181,"country":33,"countryCode":34,"cosmosGeoPoint":182,"geoPoint":186,"contacts":20},"SCRI Oncology Partners","Nashville","Tennessee","37203",{"type":36,"coordinates":183},[184,185],-86.78444,36.16589,{"lat":185,"lon":184},{"facility":188,"status":29,"city":189,"state":190,"zip":191,"country":33,"countryCode":34,"cosmosGeoPoint":192,"geoPoint":196,"contacts":20},"University of Virginia","Charlottesville","Virginia","22903",{"type":36,"coordinates":193},[194,195],-78.47668,38.02931,{"lat":195,"lon":194},{"facility":198,"status":199,"city":200,"state":20,"zip":201,"country":202,"countryCode":203,"cosmosGeoPoint":204,"geoPoint":208,"contacts":20},"Herlev Gentofte Hospital","NOT_YET_RECRUITING","Herlev","2730","Denmark","DK",{"type":36,"coordinates":205},[206,207],12.43998,55.72366,{"lat":207,"lon":206},{"type":210,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100537335","phase-1-phase-1-safety-and-tolerability-study-of-xmab541-in-advanced-solid-tumors-100537335",false,"NCT06276491","Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors","A Phase 1, First-in-Human, Dose Escalation and Expansion Study to Evaluate the Safety and Tolerability of XmAb541 in Advanced Solid Tumors","Key Inclusion Criteria:\n\n* Age ≥ 18 years. For US only: subjects with GCTs, age ≥15 years\n* CLDN6+ tumor\n* Histological or cytological documentation of locally advanced, recurrent, or metastatic ovarian, fallopian tube, or peritoneal cancer, adenocarcinoma of the endometrium (endometrial cancer, uterine cancer, or carcinoma of the uterine corpus), GCT resistant to previous treatment\n* Adequate Eastern Cooperative Oncology Group performance status\n* Life expectancy ≥ 3 months\n* Adequate liver, kidney, and bone marrow function\n\nKey Exclusion Criteria:\n\n* Patients with treated brain metastases may participate, provided they are radiologically stable.\n* Active known or suspected autoimmune disease\n* Have any condition requiring systemic treatment with corticosteroids, prednisone equivalents, or other immunosuppressive medications within 14 days prior to first dose of study drug\n* Clinically significant cardiovascular, pulmonary or gastrointestinal disease\n* Active hepatitis B or hepatitis C","ALL","15 Years",{"count":221,"type":222},282,"ESTIMATED","INTERVENTIONAL",[225],"PHASE1","The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will also evaluate the effect of XmAb541 on tumor outcomes.",[228,229,230,231,232],"Ovarian Cancer","Endometrial Cancer","Germ Cell Tumor","Testicular Germ Cell Tumor","Ovarian Germ Cell Tumor",[234,228,235,236,230,229,237],"Phase 1","CLDN6","Testicular Cancer","T-cell Engager","2026-06-09",{"date":240,"type":241},"2026-06-11","ACTUAL",{"date":243,"type":241},"2024-04-04",{"date":245,"type":222},"2028-12",{"name":5,"class":6},18]